ZURICH/BERLIN, March 26 (Reuters) - The Swiss blue-chip SMI was seen opening 0.1 percent higher at 9,310 points on Tuesday, according to premarket indications by bank Julius Baer .
Here are some of the main factors that may affect Swiss stocks on Tuesday:
* Investis Holding said it has reduced its stake in the hotel and resort project company La Foncière de la Dixence SA to 41.7 percent.
*Novartis' Sandoz said it launched the availability of Treprostinil Injection in the United States, sold by United Therapeutics Corporation, including 180 days of marketing exclusivity.
* Sika said it was expanding its production facility in Senegal by opening an mortar factory at its existing site in Dakar.
* Cassiopea announced positive results from a phase III study for its Winlevi product.
* Huber + Suhner - Abegg Holding, one of the company's biggest shareholders, said it has sold 2 million shares - equivalent to 10.04 percent - in Huber + Suhner at 75 francs per share in an accelerated book building.
No major Swiss economic data scheduled. (Reporting by Zurich newsroom and Berlin Speed Desk)